Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new Cancer Research grant will help them develop early detection methods for one of the leading causes of cancer death in the UK.

Deborah Goberdhan and Elizabeth Bird-Lieberman from the Translational Gastroenterology Unit of the Experimental Medicine Division, John Radcliffe Hospital, have been awarded a Cancer Research UK Primer grant of £100,000 to study ‘Serum extracellular vesicle signatures as biomarkers for non-invasive early detection of oesophageal adencarcinoma

Read the full article

Similar stories

New vaccine trial for Middle East Respiratory Syndrome launched

A new clinical trial to find a vaccine to protect people against Middle East Respiratory Syndrome (MERS) launched on 15 September 2023. This is the third Phase I clinical trial of the ChAdOx1 MERS vaccine, developed by researchers at the Pandemic Sciences Institute. It is the first trial in older people.